ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 23 filers reported holding ATYR PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,885 | -83.9% | 92,332 | -78.0% | 0.00% | -100.0% |
| Q2 2023 | $908,474 | +244.4% | 420,590 | +234.8% | 0.00% | +100.0% |
| Q1 2023 | $263,794 | -25.9% | 125,616 | -22.7% | 0.00% | 0.0% |
| Q4 2022 | $355,958 | -34.1% | 162,538 | -9.7% | 0.00% | -50.0% |
| Q3 2022 | $540,000 | +6.9% | 180,014 | +0.8% | 0.00% | 0.0% |
| Q2 2022 | $505,000 | -59.9% | 178,557 | -24.1% | 0.00% | -50.0% |
| Q1 2022 | $1,259,000 | -65.4% | 235,237 | -51.7% | 0.00% | -50.0% |
| Q4 2021 | $3,638,000 | -26.0% | 486,993 | -10.1% | 0.01% | -27.3% |
| Q3 2021 | $4,919,000 | +6927.1% | 541,721 | +3650.0% | 0.01% | – |
| Q2 2021 | $70,000 | -61.5% | 14,446 | -69.1% | 0.00% | -100.0% |
| Q4 2020 | $182,000 | -63.0% | 46,826 | -69.3% | 0.00% | -50.0% |
| Q3 2020 | $492,000 | -16.2% | 152,474 | +15.4% | 0.00% | -33.3% |
| Q2 2020 | $587,000 | +226.1% | 132,123 | +105.6% | 0.00% | +200.0% |
| Q1 2020 | $180,000 | – | 64,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 282,420 | $1,511,000 | 2.38% |
| Tikvah Management LLC | 1,350,833 | $7,227,000 | 2.31% |
| Stonepine Capital Management, LLC | 601,580 | $3,218,000 | 1.34% |
| VR Adviser, LLC | 1,398,889 | $7,484,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $5,957,000 | 1.19% |
| Deep Track Capital, LP | 1,028,515 | $5,503,000 | 0.35% |
| FEDERATED HERMES, INC. | 5,222,250 | $27,939,000 | 0.06% |
| Alyeska Investment Group, L.P. | 760,798 | $4,070,000 | 0.04% |
| Ikarian Capital, LLC | 37,017 | $197,000 | 0.03% |
| Baker Brothers Advisors | 625,000 | $3,344,000 | 0.02% |